On May 23, 2016, the board of Viatar CTC Solutions Inc. appointed David Boral, Thomas Gallo and David Tierney as members of the board effective immediately. On May 23, 2016, the board of the company appointed Jack Stover as a member of the board effective as of July 1, 2016. Since February 2016 David Boral has been serving as the Managing Director, Business Development of Aeon Fund. From December 2014 to April 2015, Mr. Boral served as the Vice President of Fantex Holdings, and from December 2011 to June 2014 he served as the Vice President of Costal Equities/John Carris Investments. In 2014 Thomas Gallo founded Strategic Advisory Group @ Corinthian Partners (SAG), and served as SAG's Senior Managing Director from February 2014 to June 2015. In June 2015, Mr. Gallo shifted SAG to Newbridge Securities (NBS). Since June 2015 Mr. Gallo has been serving as the Senior Managing Director at SAG at NBS. Since March 2014, David Tierney has served as the Chief Executive Officer of Icon Bioscience Inc. From February 2013 to March 2014 he was a Venture Partner at Signet Healthcare Partners. Since December 2015, Jack Stover has served as the interim President, Chief Executive Officer and a member of the board of directors of Interpace Diagnostics Group Inc. Since September 2013 Mr. Stover has also served as the Chief Executive Officer of Zebec Therapeutics LLC. Since May 2016 Mr. Stover has served as a member of the board of directors and chairman of the audit committee of Onconova Therapeutics Inc., and since June 2015 he has served as a member of the board of directors of Cernostics Inc.